Minerva Biotechnology and Biomolecular Research

Scope & Guideline

Innovating Tomorrow's Solutions Through Cutting-Edge Research

Introduction

Explore the comprehensive scope of Minerva Biotechnology and Biomolecular Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Minerva Biotechnology and Biomolecular Research in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2724-542x
PublisherEDIZIONI MINERVA MEDICA
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 2021 to 2024
AbbreviationMINERVA BIOTECHNOL B / Minerva Biotechnol. Biomolecular Res.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY

Aims and Scopes

Minerva Biotechnology and Biomolecular Research focuses on the intersection of biotechnology, molecular biology, and biomedical research, emphasizing innovative approaches to understanding and treating human diseases.
  1. Biotechnology Applications in Health Sciences:
    The journal explores various applications of biotechnology, particularly in health sciences, focusing on the development of novel therapeutic strategies and diagnostic tools.
  2. Molecular Mechanisms of Disease:
    Research published in the journal investigates the molecular and genetic underpinnings of diseases, aiming to elucidate pathways and mechanisms that could be targeted for treatment.
  3. Innovative Therapeutics and Drug Development:
    A core area of focus includes the discovery and development of new drugs, including the use of natural products, nanoparticles, and biopharmaceuticals in therapeutic contexts.
  4. Cancer Research and Therapeutics:
    The journal consistently emphasizes cancer research, exploring genetic, biochemical, and immunological aspects to improve treatment outcomes and patient care.
  5. In-silico and Computational Studies:
    There is a significant focus on in-silico approaches for drug discovery and biomarker identification, reflecting the growing importance of computational methods in biological research.
  6. Environmental and Plant Biotechnology:
    Research on the environmental applications of biotechnology, including the green synthesis of nanoparticles and the use of plant-derived compounds for health benefits, is also a notable area of interest.
Recent publications in Minerva Biotechnology and Biomolecular Research highlight several emerging themes that reflect current scientific priorities and innovations in biotechnology and molecular research.
  1. Precision Medicine and Genomics:
    An increasing focus on precision medicine, especially regarding genetic testing and tailored therapies, is evident, showcasing the journal's commitment to advancing personalized healthcare.
  2. Immunotherapy and Cancer Treatment:
    Emerging themes in immunotherapy, especially in the context of cancer treatment, indicate a growing interest in harnessing the immune system for therapeutic benefits.
  3. Sustainable and Green Biotechnology:
    There is a notable trend towards sustainable practices in biotechnology, including the green synthesis of nanoparticles and the use of plant-based compounds, reflecting a broader environmental consciousness.
  4. CRISPR and Gene Editing Technologies:
    The rise of CRISPR and other gene editing technologies as a research focus indicates the journal's alignment with cutting-edge advancements in molecular biology.
  5. Microbiome Research:
    Research exploring the human microbiome and its implications for health and disease is gaining traction, suggesting an increasing interest in the interplay between microbiota and human health.
  6. COVID-19 Related Research:
    Given the global pandemic, there has been a surge in research related to COVID-19, including vaccine development and the understanding of viral mechanisms, which continues to dominate recent publications.

Declining or Waning

Certain themes within Minerva Biotechnology and Biomolecular Research appear to be diminishing in prominence, as indicated by a decline in published works or reduced focus in recent years.
  1. Traditional Pharmacology:
    There seems to be a waning interest in traditional pharmacological studies, potentially due to the shift towards more innovative and targeted therapeutic approaches.
  2. Basic Research Without Clinical Implications:
    There is a noticeable decline in studies that focus solely on basic biological research without clear implications for clinical practice, as the journal increasingly emphasizes translational research.
  3. General Studies on Infectious Diseases:
    While infectious diseases remain a relevant topic, studies that do not provide novel insights into treatment or prevention strategies may be receiving less attention.
  4. Animal Models in Drug Testing:
    Research utilizing animal models for drug testing appears to be less frequent, possibly due to ethical concerns and a growing preference for alternative methods, including in-vitro and in-silico studies.

Similar Journals

Biomedical and Biotechnology Research Journal

Unlocking potential through cutting-edge biomedical research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2588-9834Frequency: 4 issues/year

Biomedical and Biotechnology Research Journal is a pioneering, peer-reviewed Open Access platform dedicated to the advancement of knowledge in the fields of biomedical science and biotechnology. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS since 2017, this journal offers a vital resource for researchers, professionals, and students alike, encompassing a wide range of topics from molecular biology to innovative biotechnological applications. With an impact factor reflecting its commitment to quality research, it proudly ranks in the Q3 category for Biotechnology in 2023 and holds significant positions in Scopus ranks, emphasizing its relevance in the medical and biochemistry sectors. The journal is based in India, and with its open access model, it ensures that cutting-edge research is readily available to a global audience, fostering collaboration and innovation in the rapidly evolving world of biomedicine.

ELECTRONIC JOURNAL OF BIOTECHNOLOGY

Unlocking Knowledge in Applied Microbiology and Biotechnology
Publisher: PONTIFICIA UNIV CATOLICA VALPARAISOISSN: 0717-3458Frequency: 6 issues/year

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

Biomolecules

Unlocking the secrets of life through biomolecular research.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

Bioengineered

Unlocking the Potential of Biotechnology
Publisher: TAYLOR & FRANCIS INCISSN: 2165-5979Frequency: 1 issue/year

Bioengineered, published by TAYLOR & FRANCIS INC, is an esteemed Open Access journal that has been at the forefront of research in the fields of bioengineering, biotechnology, and applied microbiology since its inception in 2012. With an impressive impact factor reflecting its high-quality contributions, the journal is categorized in the top quartiles, achieving Q1 rankings in Applied Microbiology and Biotechnology, as well as in Biotechnology and Medicine (Miscellaneous) for 2023. This active engagement in showcasing pioneering research is critical for professionals and students alike, facilitating access to revolutionary studies and methodologies. The journal operates under an Open Access model since 2018, ensuring that groundbreaking findings in bioengineering are readily accessible to a global audience. Situated in the United Kingdom, Bioengineered not only serves as a platform for innovative research but also underscores the importance of interdisciplinary collaborations among scientists, engineers, and biotechnologists.

BIOTECHNOLOGY LETTERS

Pioneering Discoveries in Applied Microbiology and Bioengineering
Publisher: SPRINGERISSN: 0141-5492Frequency: 12 issues/year

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

Biotechnology Journal

Elevating the impact of biotechnology in modern science.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-6768Frequency: 12 issues/year

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

CURRENT ISSUES IN MOLECULAR BIOLOGY

Pioneering Insights into Molecular Genetics and Microbiology
Publisher: MDPIISSN: 1467-3037Frequency: 12 issues/year

CURRENT ISSUES IN MOLECULAR BIOLOGY, published by MDPI, serves as an essential forum for researchers and professionals in the rapidly evolving field of molecular biology. Established in 1999 and operating under an Open Access model, this journal not only shares high-quality research but also encourages a vibrant exchange of ideas across various disciplines, including medicine and microbiology. With an impressive trajectory leading into 2024, it has earned its place in the Q2 quartile for both Medicine (miscellaneous) and Microbiology, emphasizing its relevance and impact in these areas. The journal’s commitment to disseminating cutting-edge findings is reflected in its diverse coverage of topics, from molecular genetics to microbial interactions. Operating from its home base in Basel, Switzerland, CURRENT ISSUES IN MOLECULAR BIOLOGY is positioned to contribute significantly to the academic landscape, making it indispensable for those seeking to advance their understanding and research within the life sciences.

Chemical Biology Letters

Advancing the Frontiers of Chemical Biology
Publisher: ScienceIn PublicationsISSN: Frequency: 1 issue/year

Chemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.

AIMS Molecular Science

Advancing Molecular Discoveries for a Global Audience
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2372-0301Frequency: 4 issues/year

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

International Journal of Biological Sciences

Exploring the Depths of Biological Knowledge
Publisher: IVYSPRING INT PUBLISSN: 1449-2288Frequency: 10 issues/year

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.